Researchers are excited about the medication , a groundbreaking dual compound showing promising outcomes in clinical trials for body loss . It works by targeting two pathways : GLP-1 and GIP, these, https://kallumywme285934.blogkoo.com/a-new-possibility-for-body-reduction-60390874